Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 9/20 | 0.58 |
| ▸ | ESR2 | Q92731 | 8/20 | 0.58 |
| ▸ | MAOA | P21397 | 3/20 | 0.58 |
| ▸ | MAOB | P27338 | 3/20 | 0.58 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.58 |
| ▸ | PTPRC | P08575 | 1/20 | 0.57 |
| ▸ | CA1 | P00915 | 1/20 | 0.56 |
| ▸ | CA2 | P00918 | 1/20 | 0.56 |
| ▸ | CA7 | P43166 | 1/20 | 0.56 |
| ▸ | CA9 | Q16790 | 1/20 | 0.56 |
| ▸ | IDO1 | P14902 | 1/20 | 0.48 |
| ▸ | CDC25B | P30305 | 1/20 | 0.48 |
| ▸ | AKT1 | P31749 | 1/20 | 0.48 |
| ▸ | SNCA | P37840 | 1/20 | 0.48 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.48 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.48 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.48 |
| ▸ | NSD1 | Q96L73 | 1/20 | 0.48 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.48 |
| ▸ | CDC25A | P30304 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8221556 | 0.81 | PTPRC (0.59) | ESR1ESR2MAOAMAOBUGT1A1 | |
| SCHEMBL8232660 | 0.81 | PTPRC (0.77) | ESR1ESR2MAOAMAOBUGT1A1 | |
| SCHEMBL30598693 | 0.81 | PTPRC (0.59) | ESR1ESR2MAOAMAOBUGT1A1 | |
| SCHEMBL11052384 | 0.75 | S100A4 (0.58) | ESR1ESR2MAOAMAOBPTPRC | |
| SCHEMBL23111390 | 0.74 | ESR2 (0.80) | ESR1ESR2MAOAMAOBUGT1A1 | |
| Anthraflavicacid SCHEMBL124974 | 0.74 | ESR2 (1.00) | ESR1ESR2MAOAMAOBUGT1A1 | |
| SCHEMBL29486239 | 0.74 | ESR2 (0.90) | ESR1ESR2MAOAMAOBUGT1A1 | |
| Anthraflavicacid SCHEMBL29985684 | 0.74 | ESR2 (1.00) | ESR1ESR2MAOAMAOBUGT1A1 | |
| SCHEMBL539276 | 0.74 | ESR2 (0.90) | ESR1ESR2MAOAMAOBUGT1A1 | |
| Anthraflavicacid SCHEMBL31105422 | 0.74 | ESR2 (1.00) | ESR1ESR2MAOAMAOBUGT1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3280402-B1 | TOLAN COMPOUNDS FOR PROMOTING WOUND HEALING | BIOMENDICS LLC (US) | 2024-06-05 | — | — | EP | claimed |
| CN-117024408-A | 1,2, 3-triaryl substituted benzo [ f ] isoindole-4, 9-dione compound and preparation method and application thereof | 湘潭大学 | 2023-11-10 | — | — | CN | claimed |
| US-20250295121-A1 | COMPOSITIONS, SYSTEMS, AND METHODS FOR INCREASED PLANT QUALITY | RDX-N, LLC | 2025-09-25 | — | — | US | disclosed |
| EP-4601469-A1 | COMPOSITIONS, SYSTEMS, AND METHODS FOR INCREASED PLANT QUALITY | RDX-N, LLC (US) | 2025-08-20 | — | — | EP | disclosed |
| US-12349681-B2 | Compositions, systems, and methods for increased plant quality | RDX-N, LLC (US) | 2025-07-08 | — | — | US | disclosed |
| EP-3280402-B1 | TOLAN COMPOUNDS FOR PROMOTING WOUND HEALING | BIOMENDICS LLC (US) | 2024-06-05 | — | — | EP | disclosed |
| US-20240122187-A1 | COMPOSITIONS, SYSTEMS, AND METHODS FOR INCREASED PLANT QUALITY | RDX-N, LLC | 2024-04-18 | — | — | US | disclosed |
| WO-2024081610-A1 | COMPOSITIONS, SYSTEMS, AND METHODS FOR INCREASED PLANT QUALITY | Ag Nutrients, LLC (US) | 2024-04-18 | — | — | WO | disclosed |
| CN-107847466-B | Formulations and methods for modulating wound healing | 贝欧曼蒂克丝公司 | 2024-02-06 | — | — | CN | disclosed |
| EP-4153555-B1 | PHOTOOXIDATION OF PHENOLIC COMPOUNDS | DSM IP ASSETS BV (NL) | 2024-01-31 | — | — | EP | disclosed |
| CN-117024408-A | 1,2, 3-triaryl substituted benzo [ f ] isoindole-4, 9-dione compound and preparation method and application thereof | 湘潭大学 | 2023-11-10 | — | — | CN | disclosed |
| US-20020061921-A1 | Novel compounds | BIOVITRUM AB (SE) | 2002-05-23 | — | — | US | disclosed |
| WO-2002026707-A1 | NOVEL COMPOUNDS | BIOVITRUM AB (SE) | 2002-04-04 | — | — | WO | disclosed |
| EP-0439585-B1 | IMMOBILISATION OF LIGANDS BY RADIO-DERIVATIZED POLYMERS | MAG GEORG MAYRHOFER & CO OHG (AT) | 1997-10-29 | — | — | EP | disclosed |
| EP-0320227-B1 | Method of preventing polymer-scale formation | SHINETSU CHEMICAL CO (JP) | 1994-09-07 | — | — | EP | disclosed |
| US-5196478-A | Polystyrene, assays | EPIPHARM ALLERGIE-SERVICE GESELLSCHAFT M.B.H. (AT) | 1993-03-23 | — | — | US | disclosed |
| EP-0439585-A1 | IMMOBILISATION OF LIGANDS BY RADIO-DERIVATIZED POLYMERS. | EPIPHARM ALLERGIE SERVICE (AT) | 1991-08-07 | — | — | EP | disclosed |
| WO-1991002768-A1 | IMMOBILISATION OF LIGANDS BY RADIO-DERIVATIZED POLYMERS | EPIPHARM ALLERGIE-SERVICE GESELLSCHAFT M.B.H. (AT) | 1991-03-07 | — | — | WO | disclosed |
| US-4933399-A | COATING INSIDE OF VESSEL WITH A CATIONIC DYE, DRYING, COATING WITH AN ANIONIC OR AMPHOTERIC POLYMER OR A HYDROXYL-CONTAINING COMPOUND IN A SOLVENT | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1990-06-12 | — | — | US | disclosed |
| EP-0320227-A2 | Method of preventing polymer-scale formation | Shin-Etsu Chemical Co., Ltd. (JP) | 1989-06-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020061921-A1 | Novel compounds | GPR119, IAPP, GLP1R | ESR1 3259/4885ESR2 395/4885MAOA 2928/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.